BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/25/2025 9:22:03 AM | Browse: 122 | Download: 241
 |
Received |
|
2024-11-18 13:28 |
|
Peer-Review Started |
|
2024-11-18 13:28 |
|
First Decision by Editorial Office Director |
|
2025-03-21 06:28 |
|
Return for Revision |
|
2025-03-21 06:28 |
|
Revised |
|
2025-05-01 17:14 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-07-11 02:42 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-07-11 05:53 |
|
Articles in Press |
|
2025-07-11 05:53 |
|
Edit the Manuscript by Language Editor |
|
2025-07-25 07:44 |
|
Typeset the Manuscript |
|
2025-09-10 07:23 |
|
Publish the Manuscript Online |
|
2025-09-25 09:22 |
| ISSN |
2220-3249 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Chronic hepatitis B: Is it time for expanded antiviral treatment?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Manish Manrai, Atul A Jha, Aditya V Pachisia and Saurabh Dawra |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Manish Manrai, Professor, Department of Gastroenterology, Command Hospital, Lucknow-226002, Lucknow 226002, Uttar Pradesh, India. manishmanrai75@gmail.com |
| Key Words |
Chronic hepatitis B; Hepatocellular carcinoma; Hepatitis B treatment guidelines; Occult B infection; Immune tolerant phase; Expanded treatment for hepatitis B |
| Core Tip |
An estimated 254 million people, almost 3.3% of the world's population, are estimated to be living with chronic hepatitis B (CHB) infection. Without therapy, they are at risk of developing cirrhosis and might develop hepatocellular cancer (HCC). The prevention of HCC is a major challenge. We review the various clinical practice guidelines and consider emerging evidence that will foster research to consider the expansion of treatment indications of CHB. |
| Publish Date |
2025-09-25 09:22 |
| Citation |
Manrai M, Jha AA, Pachisia AV, Dawra S. Chronic hepatitis B: Is it time for expanded antiviral treatment? World J Virol 2025; 14(3): 103347 |
| URL |
https://www.wjgnet.com/2220-3249/full/v14/i3/103347.htm |
| DOI |
https://dx.doi.org/10.5501/wjv.v14.i3.103347 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
